Transcript
Page 1: Non-Invasive Prenatal Testing (NIPT) Market- - · PDF file... Global Industry Analysis, Size, Share, Growth, Trends and Forecast, ... Non-Invasive Prenatal Testing (NIPT) Market- Global

REPORT DESCRIPTION

Non-Invasive Prenatal Testing (NIPT) Market Expected to Reach USD 3.62 Billion Globally in 2019: Transparency Market Research

According to a new market report published by Transparency Market Research, "Non-

Invasive Prenatal Testing (NIPT) Market (MaterniT21 PLUS, verifi, Harmony,

Panorama, NIFTY, PrenaTest and BambniTest) - Global Industry Analysis, Size,

Share, Growth, Trends and Forecast, 2013 - 2019" the global NIPT market was valued

at USD 0.22 billion in 2012 and is expected to grow at a CAGR of 37.6% from 2013 to 2019,

to reach an estimated value of USD 3.62 billion in 2019.

The market for non-invasive prenatal testing is evolving rapidly due the advantages it offers

over the conventional prenatal screening and diagnostic methods such as maternal serum

screening, nuchal translucency (NT) scan, amniocentesis and chorionic villus sampling

(CVS). These advantages include safety, accuracy, and no risk of miscarriage. An NIPT is a

non-invasive genetic screening test for the common chromosomal abnormalities (trisomy

21, trisomy 18, trisomy 13, monosomy X, etc.) observed in the fetuses of high risk

Transparency Market Research

Non-Invasive Prenatal

Testing (NIPT) Market-

Global Industry Analysis, Size, Share, Growth,

Trends and Forecast, 2013 - 2019

Single User License: US $ 4795

Multi User License: US $ 7795

Corporate User License: US $ 10795

Buy Now Request Sample

Published Date: Jan 2014

68 Pages Report

Page 2: Non-Invasive Prenatal Testing (NIPT) Market- - · PDF file... Global Industry Analysis, Size, Share, Growth, Trends and Forecast, ... Non-Invasive Prenatal Testing (NIPT) Market- Global

pregnant women (above the age of 35 years). Owing to its ability to detect the presence of

chromosomal abnormalities in fetuses of pregnant women as early as 9 to 10 weeks of

gestation, the market for non-invasive prenatal testing market is witnessing a rapid

increase in demand from all parts of the world.

MaterniT21 PLUS, verifi, Harmony, Panorama, NIFTY, PrenaTest and BambniTest are the

commercially available NIPTs in the market which are based on the direct analysis of cell-

free fetal DNA in the maternal blood. In 2012, MaterniT21 (a proprietary product of

Sequenom, Inc.) accounted for the largest share (36.6%) of the global NIPT market in

terms of revenue, owing to the fact that it was the first mover in the market place. During

the forecast period 2013 to 2019, it is likely to lose some of its share due to increasing

market penetration by other aforementioned NIPTs such as Panorama and verify.

High incidence rate of babies born with certain type of chromosomal abnormalities, growing

trend of child bearing at advanced maternal age and enhanced popularity of NIPT among

gynecologists and high risk pregnant women are some of the major factors anticipated to

drive growth of the NIPT market during the forecast period. Some of the most commonly

detected chromosomal aneuploidies include Down syndrome, Edwards syndrome, Patau

syndrome and monosomy X. On the other hand, ethical and regulatory hurdles are expected

to pose significant challenges before the NIPT market to grow. Various professional

committees across the world believe that the implementation of NIPT and the subsequent

rise in uptake of prenatal testing is likely to increase the incidence of abortions. Therefore,

professional groups such as The American College of Obstetricians and Gynecologists

(ACOG), International Society for Prenatal Diagnosis and The Japan Society of Obstetrics

and Gynecology have set up guidelines that limit the use of non-invasive prenatal testing

only to pregnant women at high risk of chromosomal aneuploidies.

Geographically, North America was the largest regional market in 2012 with a market share

of 64.5% of the total revenue generated globally, followed by Europe. Almost every

company operating in this market is adopting the same business model of marketing their

tests via alliances with hospitals, diagnostic laboratories and physician offices. The

increasing penetration by test developers in European, Asia-Pacific and Middle-East

countries indicates promising growth in the near future in these markets. Sequenom, Inc.,

Verinata Health, Inc. (now a part of Illumina, Inc.), Ariosa Diagnostics, Natera, Inc., BGI

Health, LifeCodexx and Berry Genomics are the companies engaged in providing non-

invasive prenatal tests worldwide.

Page 3: Non-Invasive Prenatal Testing (NIPT) Market- - · PDF file... Global Industry Analysis, Size, Share, Growth, Trends and Forecast, ... Non-Invasive Prenatal Testing (NIPT) Market- Global

The global non-invasive prenatal testing market is segmented as follows:

Non-Invasive Prenatal Testing Market, by Test

MaterniT21 PLUS

verifi

Harmony

Panorama

NIFTY

PrenaTest

BambniTest

Non-Invasive Prenatal Testing Market, by Geography

North America

Europe

Asia-Pacific

Rest of the World (RoW)

TABLE OF CONTENT

Chapter 1 Preface

1.1 Report Description

1.2 Market Segmentation

1.3 Research Methodology

1.3.1 Sources

1.3.1.1 Secondary Research

1.3.1.2 Primary Research

1.3.2 Models

Chapter 2 Executive Summary

Page 4: Non-Invasive Prenatal Testing (NIPT) Market- - · PDF file... Global Industry Analysis, Size, Share, Growth, Trends and Forecast, ... Non-Invasive Prenatal Testing (NIPT) Market- Global

Browse the full report with complete TOC:

http://www.transparencymarketresearch.com/noninvasive-prenatal-diagnostics-

market.html

Chapter 3 Global Non-Invasive Prenatal Testing Market Overview

3.1 Introduction

3.2 Major Chromosomal Aneuploidies and their Incidence Rate

3.2.1 Down Syndrome

3.2.2 Edwards Syndrome

3.2.3 Patau Syndrome

3.2.4 Turner Syndrome

3.2.5 Klinefelter Syndrome

3.2.6 Jacobs Syndrome

3.2.7 Triple X Syndrome

3.3 Technological Approach for NIPT

3.4 Market Drivers

3.4.1 High incidence rate of babies born with Down syndrome

3.4.2 Rise in average maternal age

3.4.3 Increasing demand for early and non-invasive fetal testing procedures

3.5 Market Restraints

3.5.1 Regulatory guidelines and ethical hurdles

3.5.2 Limitations of NIPT

3.5.3 Availability of other screening and testing methods

3.6 Market Opportunities

3.6.1 Capitalizing on the potential presented by the emerging markets of Asia

3.7 Porter’s Five Force Analysis for the Global Non-Invasive Prenatal testing Market

3.7.1 Bargaining power of suppliers

Page 5: Non-Invasive Prenatal Testing (NIPT) Market- - · PDF file... Global Industry Analysis, Size, Share, Growth, Trends and Forecast, ... Non-Invasive Prenatal Testing (NIPT) Market- Global

3.7.2 Bargaining power of buyers

3.7.1 Threat of substitutes

3.7.2 Threat of new entrants

3.7.3 Competitive rivalry

3.8 Market Attractiveness Analysis: Global Non-Invasive Prenatal Testing Market, by

Geography

Related & Recently Published Reports by Transparency Market Research

Broadcast Switchers Market: http://www.transparencymarketresearch.com/broadcast-

switchers-market.html

Refrigerated Display Cases (Plug-in and Remote) Market:

http://www.transparencymarketresearch.com/refrigerated-display-cabinets.html

Physical Security (Hardware, Software and Services) Market:

http://www.transparencymarketresearch.com/physical-security-market.html

Anti-aging Market: http://www.transparencymarketresearch.com/anti-aging-market.html

Teleradiology Market: http://www.transparencymarketresearch.com/teleradiology-

technology-Market.html

Chapter 4 Global Non-Invasive Prenatal Testing Market Revenue, by Test, 2012 -

2019 (USD Million)

4.1 Overview

4.1.1 Global Non-Invasive Prenatal Testing Market Revenue, by Test, 2012 – 2019 (USD

Million)

4.1.2 Comparative Analysis: Global Non-Invasive Prenatal Testing Market Revenue, by

Test, 2012 & 2019 (Value %)

4.2 MaterniT21 PLUS

4.2.1 Global MaterniT21 PLUS Test Market Revenue, 2012 – 2019 (USD Million)

4.3 Harmony Prenatal Test

4.3.1 Global Harmony Test Market Revenue, 2012 – 2019 (USD Million)

4.4 verifi Prenatal Test

4.4.1 Global verifi Test Market Revenue, 2012 – 2019 (USD Million)

Page 6: Non-Invasive Prenatal Testing (NIPT) Market- - · PDF file... Global Industry Analysis, Size, Share, Growth, Trends and Forecast, ... Non-Invasive Prenatal Testing (NIPT) Market- Global

4.5 Panorama Test

4.5.1 Global Panorama Test Market Revenue, 2012 – 2019 (USD Million)

4.6 Noninvasive Fetal Trisomy (NIFTY) Test

4.6.1 Global NIFTY Test Market Revenue, 2012 – 2019 (USD Million)

4.7 BambniTest

4.7.1 Global BambniTest Test Market Revenue, 2012 – 2019 (USD Million)

4.8 PrenaTest

4.8.1 Global PrenaTest Test Market Revenue, 2012 – 2019 (USD Million)

Chapter 5 Global Non-Invasive Prenatal Testing Market Revenue, by Geography,

2012 - 2019 (USD Million)

5.1 Overview

5.1.1 Global Non-Invasive Prenatal Testing Market Revenue, by Geography, 2012 -

2019 (USD Million)

5.1.2 Comparative Analysis: Global Non-Invasive Prenatal Testing Market Revenue, by

Geography, 2012 & 2019 (Value %)

5.2 North America

5.2.1 North America Non-Invasive Prenatal Testing Market Revenue, 2012 - 2019 (USD

Million)

5.3 Europe

5.3.1 Europe Non-Invasive Prenatal Testing Market Revenue, 2012 - 2019 (USD Million)

5.4 Asia-Pacific

5.4.1 Asia-Pacific Non-Invasive Prenatal Testing Market Revenue, 2012 - 2019 (USD

Million)

5.5 Rest of the World (RoW)

5.5.1 Rest of the World (RoW) Non-Invasive Prenatal Testing Market Revenue, 2012 -

2019 (USD Million)

Page 7: Non-Invasive Prenatal Testing (NIPT) Market- - · PDF file... Global Industry Analysis, Size, Share, Growth, Trends and Forecast, ... Non-Invasive Prenatal Testing (NIPT) Market- Global

Chapter 6 Competitive Landscape

6.1 Market Share Analysis, by Key Players, 2012 (%)

Chapter 7 Recommendations

7.1 Focus on improving technology in order to increase the accuracy, reduce the duration of

result generation and price

7.2 Focus on forming alliances with diagnostic service providers in European and Asia-Pacific

countries

7.3 Mergers and acquisitions

Browse the full report with complete TOC:

http://www.transparencymarketresearch.com/noninvasive-prenatal-diagnostics-

market.html

Chapter 8 Company Profiles

8.1 Ariosa Diagnostics, Inc.

8.1.1 Company Overview

8.1.2 Product Portfolio

8.1.3 Business Strategies

8.1.4 Recent Developments

8.2 Berry Genomics Co., Ltd

8.2.1 Company Overview

8.2.2 Product Portfolio

8.2.3 Business Strategies

8.2.4 Recent Developments

8.3 BGI Health

8.3.1 Company Overview

Page 8: Non-Invasive Prenatal Testing (NIPT) Market- - · PDF file... Global Industry Analysis, Size, Share, Growth, Trends and Forecast, ... Non-Invasive Prenatal Testing (NIPT) Market- Global

8.3.2 Product Portfolio

8.3.3 Business Strategies

8.4 LifeCodexx AG

8.4.1 Company Overview

8.4.2 Product Portfolio

8.4.3 Business Strategies

8.4.4 Recent Developments

8.5 Natera, Inc.

8.5.1 Company Overview

8.5.2 Product Portfolio

8.5.3 Business Strategies

8.5.4 Recent Developments

8.6 Sequenom, Inc.

8.6.1 Company Overview

8.6.2 Financial Overview

8.6.3 Product Portfolio

8.6.4 Business Strategies

8.6.5 Recent Developments

8.7 Verinata Health, Inc.

8.7.1 Company Overview

8.7.2 Product Portfolio

8.7.3 Recent Developments

Page 9: Non-Invasive Prenatal Testing (NIPT) Market- - · PDF file... Global Industry Analysis, Size, Share, Growth, Trends and Forecast, ... Non-Invasive Prenatal Testing (NIPT) Market- Global

About Us:

Transparency Market Research is a market intelligence company providing global business

information reports and services. Our exclusive blend of quantitative forecasting and trends

analysis provides forward-looking insight for thousands of decision makers.

We are privileged with highly experienced team of Analysts, Researchers and Consultants,

who use proprietary data sources and various tools and techniques to gather, and analyze

information. Our business offerings represent the latest and the most reliable information

indispensable for businesses to sustain a competitive edge.

Contact: Transparency Market Research 90 State Street, Suite 700, Albany,NY – 12207, United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-552-3453

Email: [email protected] Website: http://www.transparencymarketresearch.com/ Browse the full report with complete TOC:

http://www.transparencymarketresearch.com/noninvasive-prenatal-diagnostics-

market.html

Related Blogs: https://vaibhavmondhe.wordpress.com

https://usamarketresearch.wordpress.com/

https://pharmaceuticalmarkets.wordpress.com/

https://medicaldevicesreports.wordpress.com/ https://chemicalandmaterials.wordpress.com/


Top Related